Welcome to our dedicated page for MDB Capital Holdings SEC filings (Ticker: MDBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MDB Capital Holdings, LLC filings document the public-company governance and security structure of a Delaware limited liability company with Class A Common Shares representing limited liability interests listed on the Nasdaq Capital Market under MDBH. Current reports disclose board and audit committee appointments and other material governance events.
Proxy materials describe annual-meeting voting matters, including director elections, auditor ratification and shareholder record-date mechanics. The filings also identify the company’s registered equity class and provide formal disclosure around board composition, committee service and shareholder approval procedures.
MDB Capital Holdings, LLC operates a broker-dealer and intellectual property services platform, with a majority-owned drug development subsidiary and a large equity stake in eXoZymes. As of June 30, 2026, total assets were $50.8 million, down from $63.7 million at December 31, 2025, largely reflecting declines in investment securities and the equity method investment. Liabilities remained low at $1.3 million, leaving total equity of $49.5 million.
For the quarter ended June 30, 2026, MDB reported a net loss attributable to the company of $9.3 million, and a six‑month net loss of $16.1 million, compared with $14.9 million in the prior‑year period. Results were affected by $4.9 million in unrealized losses on broker‑dealer investment securities, a $3.1 million share of eXoZymes’ losses, and a $1.36 million dilution‑related loss. MDB also recorded a $641 thousand impairment on its equity investment in eXoZymes, reducing the carrying value to $33.1 million.
Operating activities used $5.5 million of cash in the first half of 2026, leaving cash, cash equivalents, and segregated cash of $9.9 million at June 30, 2026. The broker‑dealer subsidiary reported net capital of $8.96 million, well above regulatory minimums, and the company has an undrawn $2.0 million revolving credit facility secured by cash, indicating modest leverage but ongoing cash burn.
MDB Capital Holdings, LLC reported a net loss of 6,736 (in thousands) for the three months ended March 31, 2026, compared with a loss of 6,602 (in thousands) a year earlier. Total operating income was 44 (in thousands), as fee income of 2,862 (in thousands) and other income were largely offset by a 3,047 (in thousands) unrealized loss on investment securities at the licensed broker dealer.
General and administrative costs declined to 5,525 (in thousands) from 6,738 (in thousands), mainly from lower compensation. The equity method investment in eXoZymes generated a loss of 1,108 (in thousands), and its carrying amount was 36,339 (in thousands). Total assets were 57,463 (in thousands), and total equity was 56,224 (in thousands). Cash, cash equivalents and restricted cash totaled 12,534 (in thousands), with net cash used in operating activities of 2,945 (in thousands). As of May 14, 2026, 5,438,632 Class A Common Shares were outstanding.
MDB Capital Holdings, LLC director Daniel Thomas Torpey exercised restricted stock units (RSUs) into 20,000 shares of Common Stock. The Form 4 shows this as a derivative exercise, not an open‑market purchase or sale, with total directly held Common Stock rising to 27,100 shares after the transaction.
The filing also reports 80,000 RSUs remaining after this exercise. According to the footnote, each RSU converts into Common Stock on a one‑for‑one basis, meaning these awards function as stock-based compensation rather than cash transactions in the market.
MDB Capital Holdings, LLC director Daniel Thomas Torpey received a grant of 100,000 Restricted Stock Units on June 17, 2024 as equity compensation. The RSUs have an exercise price of $0.00 and are tied to 100,000 underlying Class A shares.
The award vests on multiple dates between June 17, 2024 and June 17, 2029, meaning the director earns the shares over time rather than all at once. Following this grant, his reported holdings in these RSUs are 100,000 units.
MDB Capital Holdings, LLC director Daniel Thomas Torpey has filed an initial ownership report showing his equity stake in the company. The filing lists direct ownership of 7,100 Class A Common Shares as of the reported date. It functions as a baseline statement of his holdings rather than a record of recent trades.
MDB Capital Holdings, LLC co-founder and director Christopher A. Marlett reported an indirect acquisition of an employee stock option covering 100,000 Class A shares on May 1, 2026. The option was granted at $0.00 per option with an exercise price of $3.56 per share and was issued to his spouse.
The grant vests over time: 20,000 shares vest one year after the grant date, and the remaining 80,000 shares vest in equal quarterly installments of 5,000 shares following each completed subsequent quarter of Continuous Service under the 2022 Equity Performance Plan. After this award, indirect holdings in this option series total 1,000,000 underlying shares, and the option expires on May 1, 2036.
MDB Capital Holdings CFO James Jeremy William reported equity-based acquisitions of company stock. On February 9, 2026, he received 10,000 shares of Common Stock as a grant at $3.90 per share, increasing his direct holdings to 39,839 shares.
On April 20, 2026, he exercised 10,000 RSUs into 10,000 shares of Class A Common Stock at a conversion price of $0.00. Following this derivative exercise, his direct ownership rose to 50,000 shares. The filing shows only acquisitions, with no reported sales or tax-withholding dispositions.
MDB Capital Holdings, LLC director Torpey Daniel Thomas reported acquiring additional equity in the company. On April 20, 2026, he received 10,000 shares of Common Stock at a stated value of $3.90 per share as a grant or award, bringing his direct Common Stock holdings to 47,100 shares after the transaction. The same day, he also exercised 10,000 RSUs at a conversion price of $0.00 per unit into 10,000 underlying Class A shares, a derivative exercise that increased his equity exposure without any reported open-market buying or selling.
MDB Capital Holdings director Sean James Magennis increased his direct stake through compensation-related equity events. On April 20, 2026, he exercised 10,000 RSUs into Class A shares at an exercise price of $0.00 per share. Earlier, on February 9, 2026, he received a grant of 10,000 shares of common stock at a reference price of $3.90 per share. After these acquisitions, he directly owned 50,000 shares of MDB Capital Holdings common stock.
MDB Capital Holdings, LLC director Terry Jeb Barton Sr. filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows indirect ownership of 4,166 Class A Common Shares of MDB Capital Holdings, held through his spouse as of the reported date.